BioHarvest Sciences (NASDAQ:BHST – Get Free Report) and Nanophase Technologies (OTCMKTS:NANX – Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.
Risk and Volatility
BioHarvest Sciences has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500. Comparatively, Nanophase Technologies has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of current recommendations for BioHarvest Sciences and Nanophase Technologies, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| BioHarvest Sciences | 1 | 0 | 1 | 0 | 2.00 |
| Nanophase Technologies | 0 | 0 | 0 | 0 | 0.00 |
Valuation & Earnings
This table compares BioHarvest Sciences and Nanophase Technologies”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| BioHarvest Sciences | $34.51 million | 1.22 | -$11.14 million | ($0.59) | -3.64 |
| Nanophase Technologies | $37.30 million | 0.00 | -$4.39 million | $0.05 | N/A |
Nanophase Technologies has higher revenue and earnings than BioHarvest Sciences. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Nanophase Technologies, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares BioHarvest Sciences and Nanophase Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| BioHarvest Sciences | -32.54% | -76.03% | -25.30% |
| Nanophase Technologies | 5.59% | 31.49% | 6.67% |
Insider & Institutional Ownership
70.2% of Nanophase Technologies shares are owned by institutional investors. 5.1% of Nanophase Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Summary
Nanophase Technologies beats BioHarvest Sciences on 10 of the 13 factors compared between the two stocks.
About BioHarvest Sciences
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
About Nanophase Technologies
Nanophase Technologies Corporation, a science-driven company, develops, manufactures, and sells integrated family of nanomaterial technologies in the United States. It engages in engineered materials, formulation development, and commercial manufacturing. The company produces engineered nanomaterial products comprising antimony, bismuth, cerium, iron, and zinc oxide for use in a various markets, including surface finishing,exterior coatings, personal care, plastics, scratch resistant coatings, and textiles. It also provides skin care formulations with mineral-based UV protection under the under the Solésence brand; and advanced material products, including architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.
Receive News & Ratings for BioHarvest Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioHarvest Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
